BP Begins Sale of Castrol in $20B Asset Divestment Strategy — Neutral
BP Zacks Investment Research — May 27, 2025BP kicks off sale of Castrol as part of a $20B divestment push, targeting a leaner portfolio and sharper focus under CEO Auchincloss.

Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale — Neutral
XAGE GlobeNewsWire — May 27, 2025Pittsburgh, PA, May 27, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we” or “our”), a company dedicated to advancing human longevity and healthy aging through regenerative bio-aesthetics, diagnostics, and nutrition, today announced the successful sale of 479,621 shares of its common stock at an average price of $4.08 per share through its at-the-market (ATM) equity offering facility. Gross proceeds from the ATM sales totaled approximately $1.96 million, prior to deducting fees and expenses.

India holds the key to Apple's next supply chain masterstroke — Positive
AAPL Proactive Investors — May 27, 2025At a glance, the mood music around Apple Inc (NASDAQ:AAPL, ETR:APC) has been unsettled. A 25% tariff threat from the Trump administration and renewed pressure to move manufacturing to the United States have cast a shadow over the tech giant's supply chain model.

Tesla Talks Big, While Alphabet And Baidu Surge Ahead In Robotaxi Race — Negative
BIDU GOOG GOOGL TSLA Benzinga — May 27, 2025Elon Musk has promised robotaxis every year since 2016 – and now, the latest vow is that Tesla Inc TSLA will launch a fleet in Austin, Texas, by June. But while Tesla talks a big game, it is Alphabet Inc's GOOGL GOOG Waymo and Baidu Inc's BIDU Apollo Go that are clocking miles and making money (or at least, showing a clear path to it).

NVDY: Why I'm Passing On A Hefty Distribution Yield Into Nvidia's Earnings (Downgrade) — Negative
NVDA Seeking Alpha — May 27, 2025NVDY: Why I'm Passing On A Hefty Distribution Yield Into Nvidia's Earnings (Downgrade)

Reasons to Add NiSource Stock to Your Portfolio Right Away — Neutral
NI Zacks Investment Research — May 27, 2025NI is a good stock to invest in the utility electric-power industry, given its earnings growth prospects and better debt management.

NUE vs. STLD: Which U.S. Steel Giant Should You Invest in Now? — Positive
NUE STLD Zacks Investment Research — May 27, 2025NUE and STLD ramp up growth plans as steel prices rebound, with both eyeing profitability through expansion, strong cash flow and shareholder returns.

Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? — Positive
PBH Zacks Investment Research — May 27, 2025PBH stock jumps on the back of brand strength, e-commerce gains and smart acquisitions despite tariff and foreign exchange headwinds.

Class Action Filed Against Compass Group Diversified Holdings, LLC (CODI) Over Securities Violations - Contact Levi & Korsinsky Today — Neutral
CODI Accesswire — May 27, 2025NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=150333&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

Securities Lawsuit Alert: Viatris Inc. (VTRS) - Contact Levi & Korsinsky Before June 3, 2025 — Neutral
VTRS Accesswire — May 27, 2025NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=150334&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

Lost Money on Cerevel Therapeutics Holdings, Inc. (ABBV)? Urged to Join Class Action Before June 3, 2025 - Contact Levi & Korsinsky — Neutral
ABBV Accesswire — May 27, 2025NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cerevel-therapeutics-holdings-inc-lawsuit-submission-form?prid=150335&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

Class Action Alert: Levi & Korsinsky Reminds Civitas Resources (CIVI) Investors of July 1, 2025 Deadline — Neutral
CIVI Accesswire — May 27, 2025NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=150332&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29 — Neutral
MNKD GlobeNewsWire — May 27, 2025WESTLAKE VILLAGE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will team up with NTT INDYCAR SERIES driver Conor Daly, who is living with Type 1 diabetes (T1D) for a one-of-a-kind experience with Detroit area youth and families during the week of the Chevrolet Detroit Grand Prix in downtown Detroit.

My 2 Favorite Big Beautiful Bargains Offering High Yields — Positive
ARE BEP Seeking Alpha — May 27, 2025The market is not always efficient. This creates opportunities to buy diamonds at regular stone prices. In this article, I elaborate on my two favorite dividend bargains.

CoreWeave Stock Brushes Off First Analyst Downgrade — Positive
CRWV Schaeffers Research — May 27, 2025CoreWeave Inc (NASDAQ:CRWV) is up 4.2% at $107.02 before the bell, extending its impressive rally since going public in late March.

Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence — Positive
BMY Seeking Alpha — May 27, 2025Despite socio-economic challenges and pressure from the generic versions of Revlimid and Abraxane, Bristol-Myers Squibb Company's financial position continues to improve. It raised its 2025 diluted EPS guidance from $6.55-$6.85 to $6.7-$7, as well as revenue expectations from $45.5 billion to $45.8-$46.8 billion. Bristol-Myers Squibb's key franchises remain oncology and cardiovascular, primarily due to the strong performance of Opdivo, Camzyos, and Reblozyl.

Nvidia made early investors rich, but there is a new class of ‘Next Nvidia Stocks' that could be even better.

Best Income Stocks to Buy for May 27th — Positive
IVR JAKK PCB Zacks Investment Research — May 27, 2025IVR, JAKK and PCB made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 27, 2025.

BB vs. CRWD: Which Cybersecurity Stock Is the Smarter Buy Now? — Negative
BB CRWD Zacks Investment Research — May 27, 2025BlackBerry gains momentum with cost cuts, strong UEM growth and top Zacks Rank, while CrowdStrike faces pressure from rising costs and outage fallout.

Champion Homes (SKY) Lags Q4 Earnings and Revenue Estimates — Negative
SKY Zacks Investment Research — May 27, 2025Champion Homes (SKY) came out with quarterly earnings of $0.65 per share, missing the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.62 per share a year ago.
